Brief: Qlife Says Hipro To Accelerate Egoo Development, Regulatory Approval In China
13/03/2026 07:34
March 13 (Reuters) - Qlife Holding AB QLIFE.ST: HIPRO TO ACCELERATE EGOO DEVELOPMENT AND REGULATORY APPROVAL IN CHINA FOLLOWING STRONG INTEREST HIPRO WILL MANAGE PRODUCT DEVELOPMENT ACTIVITIES, REGULATORY SUBMISSIONS, MANUFACTURING, AND COMMERCIALIZATION IN CHINESE MARKET. QLIFE WILL RECEIVE A ROYALTY OF 20 PERCENT ON NET SALES GENERATED FROM EGOO IN CHINA Source text: ID:nWkr7r4V7r Further company coverage: QLIFE.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))